We provide medical & scientific updates from Legend Biotech. Intended for US HCPs only. See pinned post for inquiries and community guidelines.

Somerset, NJ
Joined May 2025
2
652
馃摙 Grant applications are now open for the ELITE Program! Dedicated to fostering the next generation of scientific leaders in cellular therapy, ELITE recognizes and supports early- career researchers advancing innovation and impactful research. Guided by an independent Steering Committee of renowned experts. Apply today. Visit the website to learn more: bit.ly/4vuXS5i #ELITEProgram #CellularTherapy #ResearchInnovation
1
96
An estimated 36,000 new cases of multiple myeloma are projected in the U.S. in 2026. At Legend, we鈥檙e advancing cell therapy innovation to help expand access and improve outcomes, with the goal of transforming the future of care for patients. Learn more about how Legend is advancing research in Multiple Myeloma: bit.ly/3PDdJzr #MultipleMyeloma #mmsm #CellTherapy #Innovation #CART
1
58
Legend Biotech Medical Affairs retweeted
Applications are now open for Legend Biotech鈥檚 inaugural ELITE Program (Emerging Leadership & Innovation in Cell Therapy Excellence). The annual grant initiative is designed to recognize and support early-career healthcare professionals advancing novel cell therapy approaches for the treatment of multiple myeloma. Through the ELITE Program, we鈥檙e investing in the next generation of innovators and the ideas that can help advance research, education, and care for patients living with multiple myeloma. Applications are open through November 20, 2026. Learn more and apply: bit.ly/4wnt47v
2
1
2
628
Thank you for joining us at #IMS2026 Follow along for more updates
3
142
At #IMS2026, Dr. Binod Dhakal @bhemato will present real-world outcomes with BCMA-directed CAR-T therapy in earlier-line multiple myeloma. #mmsm #CART #MultipleMyeloma
3
5
331
At #IMS2026, Dr. Adam Cohen @CohenAd_MMdoc will present long-term remission and survival outcomes from CARTITUDE-2 Cohort A evaluating BCMA-directed CAR-T therapy in multiple myeloma. Stay tuned for more. #MultipleMyeloma #CART #mmsm
3
7
198
New data is coming to #IMS2026. Legend will share 5-year follow-up data from CARTITUDE-2 Cohort A. Explore the details at the link below. bit.ly/4ihwMLU
2
3
238
Legend Biotech is excited to be at #IMS2026! Stop by booth #1453 to connect with our Medical Affairs team and learn more about our commitment to advancing innovation for patients. We look forward to seeing you there. #mmsm #CART
2
149
Join us at #IMS2026, where Dr. Hermann Einsele will present the first results from a prospective postauthorization safety study of a BCMA-directed CAR-T therapy in relapsed/refractory multiple myeloma. Stay tuned for updates from the meeting. #MultipleMyeloma #CART #mmsm
3
5
256
Legend Biotech is excited to be in Scotland this week for IMS! Join us as we share new data, connect with the scientific community, and participate in discussions shaping the future of patient care. Stay tuned for updates from the meeting. #IMS2026 #mmsm #celltherapy
2
3
173
Grant applications for the ELITE Program are now open! Supporting early-career innovators in cellular therapy through collaboration, scientific excellence, and impactful research. 馃搮 Deadline: November 20, 2026 Visit the website to learn more: bit.ly/4vuXS5i
73
Legend Biotech will be in Scotland next week for #IMS2026! For the latest update on our science: bit.ly/4ihwMLU #mmsm #CART
1
88
Thank you to everyone who joined us at #SOHO2026. We look forward to sharing more data at #IMS2026. #mmsm #CART
138
Complete your Friday evening with dessert at #SOHO and hear from Dr. Krina Patel as she discusses lessons from the CARTITUDE program and real-world evidence.
4
123
At #IMS2026, Legend Biotech will share updated long-term and real-world evidence from its CAR-T clinical program. Click the link below to learn more: bit.ly/4ihwMLU
1
1
117
Legend Biotech Medical Affairs retweeted
New data is coming at #IMS26. At the 23rd International @Myeloma_Society Annual Meeting in Glasgow, Legend Biotech will present data from our CAR-T cell therapy, including long-term, post-authorization and real-world findings. These insights build on learnings from our clinical program as we continue our focus on advancing scientific innovation and reaching patients globally. Learn more about the data we鈥檒l be sharing in Glasgow: bit.ly/4xITIZj #LegendBiotech #CellTherapy #ClinicalResearch
4
1
4
715
At #SOHO2026, Dr. Roberto Mina (@RobertoMinaMD) of Emory University will present data from cytogenetic subgroup analysis examining bridging therapy in CARTITUDE-4. #CART #mmsm
4
6
256
Legend Biotech is in Houston, Texas for #SOHO2026! Follow us scientific updates. #mmsm #multiplemyeloma
1
107
The ELITE Program, sponsored by Legend Biotech, will support the next generation of scientific leaders in cellular therapy among US healthcare professionals. Learn more: bit.ly/4vuXS5i #ELITEProgram #CellTherapy #ScientificLeadership
60
Next week, Legend Biotech will be at #SOHO2026. Follow us scientific updates. #mmsm #multiplemyeloma
1
76